Capital Analysts, LLC: AVAV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Analysts, LLC on AVAV, newest first. How the timeline and the estimate are built.
Capital Analysts, LLC held 2,573 AVAV shares at 2026-09-30 per its 13F-HR filed 2026-11-13.
the latest 13F is the newest step
- period ended2026-09-3013F 2,573 sharesChange vs previous 13F +554 shares
0.01% of the 13F portfolio, value $365,932.
13F-HR 0001624758-26-000047 filed by Capital Analysts, LLC
Accepted , ingested - period ended2026-06-3013F/A 2,019 sharesChange vs previous 13F +291 shares
0.01% of the 13F portfolio, value $333,276.
13F-HR/A 0001624758-26-000016 filed by Capital Analysts, LLC
Accepted , ingested - period ended2026-03-3113F/A 1,728 sharesChange vs previous 13F +477 shares
0.01% of the 13F portfolio, value $316,310.
13F-HR/A 0001624758-26-000018 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-12-3113F/A 1,251 sharesChange vs previous 13F +1,225 shares
0.01% of the 13F portfolio, value $302,604.
13F-HR/A 0001624758-26-000020 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-09-3013F/A 26 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $8,187.
13F-HR/A 0001624758-26-000022 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-06-3013F/A 26 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $7,409.
13F-HR/A 0001624758-26-000024 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-03-3113F/A 26 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $3,099.
13F-HR/A 0001624758-26-000026 filed by Capital Analysts, LLC
Accepted , ingested - period ended2024-12-3113F/A 26 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $4,001.
13F-HR/A 0001624758-26-000028 filed by Capital Analysts, LLC
Accepted , ingested